A survey of veterinarians shows that financial constraints are common among clients managing canine atopic dermatitis and ...
Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of ...
In lieu of flea and tick season coming soon, we compiled a list of the different types of flea and tick treatments to consider for your pet.
UVB phototherapy shows similar efficacy in atopic dermatitis. Learn why narrowband UVB may offer better tolerability in this ...
Submission supported by data from INTEGUMENT-INFANT Phase 2 open-label study in infants aged 3 months to less than 24 months with mild to ...
Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company advancing next-generation bispecific antibodies for immunology and inflammation, today announced the ...
The biotech firm finished recruiting participants for a Phase 1b/2a trial of BBT001, a potential treatment for atopic ...
Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive data and initiation of Phase 2 trial during the ...
Corvus Pharmaceuticals is developing an oral drug for a common skin condition that could push its shares a lot higher, ...
Targeted treatments have emerged as a safer and more effective option for eczema patients, but high costs remain a barrier.
The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results